Doctor of Philosophy The Australian National University
Excludes commercial-in-confidence projects.
Research since 2008 is shown below. To see earlier years visit Scopus
Open access indicates that an output is open access.
Prow, NA, Liu, L, Nakayama, E, Cooper, TH, Yan, K, Eldi, P, Hazlewood, JE, Tang, B, Le, TT, Setoh, YX, Khromykh, AA, Hobson-Peters, J, Diener, KR, Howley, PM, Hayball, JD & Suhrbier, A 2018, 'A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses', Nature communications, vol. 9, article no. 1230, pp. 1-12.
Open access 1 79
Zhang, W, Song, Y, Eldi, P, Guo, X, Hayball, JD, Garg, S & Albrecht, H 2018, 'Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles', International journal of nanomedicine, vol. 13, pp. 293-305.
Open access 1 2
Eldi, P, Cooper, TH, Liu, L, Prow, NA, Diener, KR, Howley, PM, Suhrbier, A & Hayball, JD 2017, 'Production of a chikungunya vaccine using a CHO Cell and attenuated viral-based platform technology', Molecular therapy, vol. 25, no. 10. pp. 2332-2344.
Open access 2 1 1
Liu, L, Cooper, T, Eldi, P, Garcia-Valtanen, P, Diener, KR, Howley, PM & Hayball, JD 2017, 'Transient dominant host-range selection using Chinese hamster ovary cells to generate marker-free recombinant viral vectors from vaccinia virus', BioTechniques, vol. 62, no. 4, pp. 183-187.
3 3 1
Wijesundara, DK, Yu, W, Quah, BJ, Eldi, P, Hayball, JD, Diener, KR, Voskoboinik, I, Gowans, EJ & Grubor-Bauk, B 2017, 'Cytolytic DNA vaccine encoding lytic perforin augments the maturation of - and antigen presentation by - dendritic cells in a time-dependent manner', Scientific reports, vol. 7, no. 1, article no. 8530, pp. 1-8.
Open access 1 1
Tao, B, Bernardo, K, Eldi, P, Chegeni, N, Wiese, M, Colella, A, Kral, A, Hayball, J, Smith, W, Forsyth, K & Chataway, T 2016, 'Extended boiling of peanut progressively reduces IgE allergenicity while retaining T cell reactivity', Clinical and experimental allergy, vol. 46, no. 11, pp. 1004-1014.
6 5 14
Zhang, W, Garg, S, Eldi, P, Zhou, FH-h, Johnson, IR, Brooks, DA, Lam, F, Rychkov, G, Hayball, JD & Albrecht, H 2016, 'Targeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptide', International journal of pharmaceutics, vol. 513, pp.270-279.
9 6 1
Chaudhri, G, Tahiliani, V, Eldi, P & Karupiah, G 2015, 'Vaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses', Journal of Virology, vol. 89, no. 3, pp. 1889-1899.
Open access 4 4 2
Andoniou, CE, Sutton, VR, Wikstrom, ME, Fleming, P, Thia, KY, Matthews, AY, Kaiserman, D, Schuster, IS, Coudert, JD, Eldi, P, Chaudhri, G, Karupiah, G, Bird, P I, Trapani, JA & Degli-Esposti, MA 2014, 'A natural genetic variant of granzyme B confers lethality to a common viral infection', PLoS pathogens, vol. 10, no. 12, article no. e1004526, pp. 1-13.
Open access 7 6 2
Tahiliani, V, Chaudhri, G, Eldi, P & Karupiah, G 2013, 'The orchestrated functions of innate leukocytes and T cell subsets contribute to humoral immunity, virus control, and recovery from secondary poxvirus challenge', Journal of Virology.
|Australian National University||AUSTRALIA|
|Hanyang University||KOREA, REPUBLIC OF|
|John Curtin School of Medical Research||AUSTRALIA|
|Peter MacCallum Cancer Centre||AUSTRALIA|
|QIMR Berghofer Medical Research Institute||AUSTRALIA|
|Saint Louis University||UNITED STATES|
|University of Adelaide||AUSTRALIA|
|University of Melbourne||AUSTRALIA|
|University of Queensland||AUSTRALIA|
|University of South Australia||AUSTRALIA|
|University of Western Australia||AUSTRALIA|
Australian Society of Clinical Immunology and Allergy Branch meeting
Best Early Career Researcher presentation
Australasian Society for Immunology (SA/NT) Adelaide Immunology Retreat
Supervisions from 2010 shown
|Thesis title||Student status|
|Development of an immunotherapeutic approach to the prevention and treatment of endometriosis||Current|
|Enhanced multivalent vaccine responses using a novel vaccine vector system||Current|
|HMGB1: a novel player in the pathogenesis of inflammatory myositis||Current|